These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


353 related items for PubMed ID: 8105785

  • 21. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO.
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [Abstract] [Full Text] [Related]

  • 22. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis.
    Wang D, Clement P, Smitz J, De Waele M.
    Acta Otorhinolaryngol Belg; 1996 Sep; 50(1):25-32. PubMed ID: 8669268
    [Abstract] [Full Text] [Related]

  • 23. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G.
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [Abstract] [Full Text] [Related]

  • 24. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
    Grossman J, Halverson PC, Meltzer EO, Shoenwetter WF, van Bavel JH, Woehler TR, Freitag JJ, Hemsworth GR.
    Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
    [Abstract] [Full Text] [Related]

  • 25. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis.
    Pearlman DS, Grossman J, Meltzer EO.
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):258-62. PubMed ID: 14533657
    [Abstract] [Full Text] [Related]

  • 26. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
    Berger WE, Fineman SM, Lieberman P, Miles RM.
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
    [Abstract] [Full Text] [Related]

  • 27. Investigation on the efficacy and tolerance of azelastine (HCL) nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis.
    Conde Hernández J, Palma Aguilar JL, Delgado Romero J.
    Allergol Immunopathol (Madr); 1995 Jun; 23(2):51-7. PubMed ID: 8526167
    [Abstract] [Full Text] [Related]

  • 28. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA.
    Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE, White MV, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [Abstract] [Full Text] [Related]

  • 30. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
    Giede C, Metzenauer P, Petzold U, Ellers-Lenz B.
    Curr Med Res Opin; 2000 Aug; 16(3):153-63. PubMed ID: 11191004
    [Abstract] [Full Text] [Related]

  • 31. Effectiveness of azelastine nasal solution in seasonal allergic rhinitis.
    Storms WW, Pearlman DS, Chervinsky P, Grossman J, Halverson PC, Freitag JJ, Widlitz MD.
    Ear Nose Throat J; 1994 Jun; 73(6):382-6, 390-4. PubMed ID: 8076537
    [Abstract] [Full Text] [Related]

  • 32. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis.
    Kalpaklioglu AF, Kavut AB.
    Am J Rhinol Allergy; 2010 Jun; 24(1):29-33. PubMed ID: 20109317
    [Abstract] [Full Text] [Related]

  • 33. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F, Zieglmayer UP, Zieglmayer R, Kavina A, Marschall K, Munzel U, Petzold U.
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [Abstract] [Full Text] [Related]

  • 34. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W, Wiseman LR.
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [Abstract] [Full Text] [Related]

  • 35. Azelastine nasal spray for allergic rhinitis.
    Med Lett Drugs Ther; 1997 May 09; 39(1000):45-7. PubMed ID: 9150688
    [No Abstract] [Full Text] [Related]

  • 36. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis.
    Lee TA, Pickard AS.
    Pharmacotherapy; 2007 Jun 09; 27(6):852-9. PubMed ID: 17542768
    [Abstract] [Full Text] [Related]

  • 37. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH, van Bavel JH, Martin BG, Hampel FC, Howland WC, Rogenes PR, Westlund RE, Bowers BW, Cook CK.
    J Fam Pract; 1998 Aug 09; 47(2):118-25. PubMed ID: 9722799
    [Abstract] [Full Text] [Related]

  • 38. [Efficacy of topical azelastine in the treatment of allergic rhinitis caused by Parietaria officinalis].
    Pacor ML, Biasi D, Carletto A, Maleknia T, Lunardi C.
    Recenti Prog Med; 1998 Apr 09; 89(4):177-9. PubMed ID: 9612009
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
    Shah S, Berger W, Lumry W, La Force C, Wheeler W, Sacks H.
    Allergy Asthma Proc; 2009 Apr 09; 30(6):628-33. PubMed ID: 19930788
    [Abstract] [Full Text] [Related]

  • 40. Sequential therapy with azelastine in seasonal allergic rhinitis. Deutsche Rhinitis Studiengruppe (German Rhinitis Study Group).
    Kremer B, Klimek L, Gülicher D, Degen M, Mösges R.
    Arzneimittelforschung; 1999 Nov 09; 49(11):912-9. PubMed ID: 10604044
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.